Remote preconditioning by aortic constriction: affords cardioprotection as classical or other remote ischemic preconditioning? Role of iNOS

Dose remote preconditioning by aortic constriction (RPAC) affords cardioprotection similar to classical or other remote ischemic preconditioning stimulus? Moreover study was also designed to investigate role of inducible nitric oxide synthase in remote preconditioning by aortic constriction. There are sufficient evidences that "ischemic preconditioning" has surgical applications and afford clinically relevant cardioprotection. Transient occlusion of circumflex artery, renal artery, limb artery or mesenteric artery preconditions the myocardium against ischemia reperfusion injury in case of ischemic heart disease leading to myocardial infraction. Here abdominal aorta was selected to produce RPAC. Four episodes of Ischemia-reperfusion of 5 min each to abdominal aorta produced RPAC by assessment of infract size, LDH and CK. These studies suggest RPAC produced acute (FWOP) and delayed (SWOP) cardioprotective effect. RPAC demonstrated a significant decrease in Ischemia-reperfusion induced release of LDH, CK and extent of myocardial infract size. L-NAME (10 mg/Kg i.v.), Aminoguanidine (150 mg/Kg s.c.), Aminoguanidine (300 mg/Kg s.c.), S-methyl isothiourea (3 mg/Kg i.v.), 1400W (1 mg/Kg i.v.) administered 10 min. before global ischemia reperfusion produced no marked effect. Aminoguanidine (150 mg/Kg s.c.), Aminoguanidine (300 mg/Kg s.c.), S-methyl isothiourea (3 mg/Kg i.v.), 1400W (1 mg/Kg i.v.) pretreatment after RPAC produced no significant effect on acute RPAC induced decrease in LDH, CK and infract size, whereas L-NAME (10 mg/Kg i.v.) increased RPAC induced decrease in LDH, CK and infract size. Most interesting observation is in delayed RPAC, where all NOS inhibitors pretreatment attenuate RPAC induced decrease in LDH, CK and infract size. In conclusions, "Remote preconditioning by aortic constriction" (RPAC) affords cardioprotection similar to classical or other remote ischemic preconditioning stimulus. Moreover, late or delayed phase of RPAC has been mediated by inducible nitric oxide synthase (iNOS) whereas it has not involved in acute RPAC

Loan pricing model : design and implementation

Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 1996.Includes bibliographical references (leaf 40).by Ashish Sharma.M.Eng

Colliding employer-employee perspectives of employee turnover:evidence from a born-global industry

Set in the context of internationalization of the global division of labor, this article provides a deeper exploration of qualitative themes of conflicting accounts of employees’ reasons to quit and managerial strategies to prevent employee turnover in six business process outsourcing firms operating in India. Such differences in cognition and action between the two constituencies suggest that the decision to quit is not a linear and rational process as highlighted in most extant models of employee turnover. Our findings suggest that employees are attached more to a place or people they work with rather than the organization per se. Intergenerational differences between Generation Y knowledge workers and Generation X managers and the ineffectiveness of espoused human resource practices suggest the presence of “push” human resource management (HRM) systems. Our findings have implications for employee turnover models, intergenerational theory and high-commitment HRM, and practitioners

On-Demand Big Data Integration: A Hybrid ETL Approach for Reproducible Scientific Research

Scientific research requires access, analysis, and sharing of data that is distributed across various heterogeneous data sources at the scale of the Internet. An eager ETL process constructs an integrated data repository as its first step, integrating and loading data in its entirety from the data sources. The bootstrapping of this process is not efficient for scientific research that requires access to data from very large and typically numerous distributed data sources. a lazy ETL process loads only the metadata, but still eagerly. Lazy ETL is faster in bootstrapping. However, queries on the integrated data repository of eager ETL perform faster, due to the availability of the entire data beforehand. In this paper, we propose a novel ETL approach for scientific data integration, as a hybrid of eager and lazy ETL approaches, and applied both to data as well as metadata. This way, Hybrid ETL supports incremental integration and loading of metadata and data from the data sources. We incorporate a human-in-the-loop approach, to enhance the hybrid ETL, with selective data integration driven by the user queries and sharing of integrated data between users. We implement our hybrid ETL approach in a prototype platform, Obidos, and evaluate it in the context of data sharing for medical research. Obidos outperforms both the eager ETL and lazy ETL approaches, for scientific research data integration and sharing, through its selective loading of data and metadata, while storing the integrated data in a scalable integrated data repository.Comment: Pre-print Submitted to the DMAH Special Issue of the Springer DAPD Journa

The Complex Interplay of Pulmonary Kinetic Processes

The inhalation route is frequently used to administer drugs for the management of respiratory diseases such as asthma or chronic obstructive pulmonary disease. Compared with other routes of administration, inhalation offers a number of advantages in the treatment of these diseases. For example, via inhalation, a drug is directly delivered to the target organ, conferring high pulmonary drug concentrations and low systemic drug concentrations. Therefore, drug inhalation is typically associated with high pulmonary efficacy and minimal systemic side effects. The lung, as a target, represents an organ with a complex structure and multiple pulmonary-specific pharmacokinetic processes, including (1) drug particle/droplet deposition; (2) pulmonary drug dissolution; (3) mucociliary and macrophage clearance; (4) absorption to lung tissue; (5) pulmonary tissue retention and tissue metabolism; and (6) absorptive drug clearance to the systemic perfusion. In this review, we describe these pharmacokinetic processes and explain how they may be influenced by drug-, formulation- and device-, and patient-related factors. Furthermore, we highlight the complex interplay between these processes and describe, using the examples of inhaled albuterol, fluticasone propionate, budesonide, and olodaterol, how various sequential or parallel pulmonary processes should be considered in order to comprehend the pulmonary fate of inhaled drugs

Climatic benefits of black carbon emission reduction when India adopts the US on-road emission level

India is known to emit large amounts of black carbon (BC) particles, and the existing estimates of the BC emission from the transport sector in the country widely range from 72 ~ 456 Gg/year (for the 2000’s). First, we reduce the uncertainty range by constraining the existing estimates by credible isotope analysis results. The revised estimate is from 74 ~ 254 Gg/year. Second, we derive our own BC estimate of the transport section in order to gain a new insight into the mitigation strategy and value. Our estimate shows that the transport section BC emission would be reduced by about 69% by adopting the US standards. The highest emission reduction comes from the vehicles in the 5–10 year old age group. The minimum emission reduction would be achieved from the vehicles in the 15–20 year old age category since their population is comparatively small in comparison to other age categories. The 69 % of 74 ~ 254 Gg/year is 51 ~ 175 Gg/year, which is the estimated BC emission reduction by switching to the US on-road emission standard. Assuming that global BC radiative forcing is 0.88 Wm−2 for 17.8 Tg/year of BC emission, we find that the reduced BC emission translates into −0.0025 ~ −0.0087 W m−2 in global forcing. In addition, we find that 51 ~ 175 Gg of BC emission reduction amounts to 0.046 – 0.159 B carbon credits which are valued at 0.56 – 1.92 B US dollars (using today’s carbon credit price). In a nutshell, India could potentially earn billions of dollars per year by switching from the current on-road emission levels to the US levels

Seed treatments for sustainable agriculture-A review

Seed treatment refers to the application of certain agents physical, chemical or biological to the seed prior to sowing in order to suppress, control or repel pathogens, insects and other pests that attack seeds, seedlings or plants and it ranges from a basic dressing to coating and pelleting. Introduction and ban of arsenic (used from 1740 until 1808) is the key milestones in the history of modern seed treatment till then a continuous research and advancement in this technology is going on. The technological advancement prepared a roadmap for refiningexisting seed treatment technologies and future work on technologies like fluid drilling as a way to sow germinated seeds where gel can also serve as a delivery system for other materials, seed priming advances the early phase of germination without redicle emergence. Another advanced technology, solid matrix priming (SMP) has been evaluated as a means to advances the germination of seeds and serve as a carrier for useful material too. Physical and biological seed treatments alone an alternative to chemicals or in combination with a chemical treatment are being used worldwide because of their environmental safety and socioeconomic aspects. Biological seed treatments are expected to be one of the fastest growing seed treatment sectors in the near future, in part because they are easier to register at Environment Protection Agency (EPA). Lack of awareness to seed treatments at farmer’s level is one of the limiting factors in disease management and hence, efforts should be made at farmer’s level to adopt the technology. Keeping the all above facts in mind, selected seed treatment technologies with their improvement and significance will be discussed in this review